This review highlights biosynthetic strategies to enhance provitamin D3 in food, indicating promising solutions for vitamin D deficiency.
Despite various forms of vitamin supplementation being available to consumers, the number of vitamin D-deficiency cases continues to increase. This review found that there are a plethora of health risks related to vitamin D deficiency, including many neurocognitive and bodily ailments, and that one of the most effective ways of combating vitamin D deficiency is by incorporating the micronutrient into one’s diet. Furthermore, this paper explores two studies that utilize techniques such as transgenesis and mutagenesis to biosynthesize provitamin D₃ (the precursor of vitamin D₃). The first study discusses the use of horizontal gene transfer and the recombination technique—both transgenic techniques—on Saccharomyces cerevisiae (Baker’s Yeast), which led to a significant improvement of 7-DHC production. Meanwhile, the second study centres on the use of CRISPR-Cas9, a mutagenesis technique, on Solanum Lycopersicum (Moneymaker Tomato) to redirect and increase the production of 7-DHC in the fruit. Both studies produce significant yields of provitamin D₃, suggesting that there is great potential for decreasing vitamin D-deficiency cases, as well as increasing market expansion through the genetic enhancement of food production and agriculture.
No takes yet. Share an insight, caveat, or question.
Bella Zhang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: